Health experts say reversing Trump administration withdrawal from the international body is good news for the WHO, America and the world.
Author: Karen Weintraub, USA TODAY
Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports
A study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut the risk of COVID-19 by up to 80%, maker Eli Lilly announced.
Moderna struggles to find 3,000 adolescent volunteers needed for COVID-19 vaccine trial
More than 2 million minors were diagnosed with COVID-19 in 2020, and many more probably contracted the disease but were never diagnosed.
New coronavirus variants aren’t cause for alarm yet, but mutations could make COVID-19 harder to fight, experts say
The two authorized COVID-19 vaccines and others under development are expected to continue to be effective against the new strains of the coronavirus.
Monoclonal antibodies may have helped Donald Trump recover from COVID-19, but many others aren’t getting them
Monoclonal antibodies mimic the natural process of the immune system, providing it with molecules the body normally manufactures to fight disease.
US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use
Moderna’s COVID vaccine, the second cleared for use in the U.S., will be shipped this weekend, with first doses expected to be given Monday.
FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting
An FDA advisory panel is expected Thursday to recommend authorization of the COVID-19 vaccine developed by Moderna. It could be in states by Monday.
German scientist Özlem Türeci was focused on cancer at BioNTech, then came COVID-19. It was her ‘duty’ to help develop a vaccine.
When Özlem Türeci, co-founder of BioNTech, first heard about the novel coronavirus, she knew her company would have to work on a vaccine to fight it.
Effectiveness and safety of Moderna COVID vaccine confirmed, path cleared for expected authorization this week
Data released Tuesday confirms Moderna’s COVID-19 vaccine is safe and effective. FDA is expected to clear the nation’s second vaccine by week’s end.
‘A historic event for humanity’: US reaches turning point in fight against COVID-19 as FDA authorizes Pfizer vaccine
The FDA authorization clears the way for Americans to begin receiving Pfizer’s vaccine. First in line: Health care workers and nursing home residents.